期刊文献+

促肾上腺皮质激素治疗婴儿痉挛42例不同剂量与疗效及副作用相关性观察 被引量:5

下载PDF
导出
摘要 目的:探讨促肾上腺皮质激素治疗婴儿痉挛的剂量与疗效及副作用之间的关系。方法:将42例婴儿痉挛患儿随机分为ACTH大剂量组(每天4U/kg)、中剂量组(每天2U/kg)和小剂量组(每天1U/kg)进行治疗,治疗期间严密观察记录治疗效果和副作用。结果:ACTH大剂量、中剂量与小剂量治疗婴儿痉挛的总有效率(完全控制+有效)分别为92.9%、92.9%和85.7%,副作用发生率分别为92.9%、42.9%和35.7%。结论:中剂量ACTH的治疗效果接近大剂量,但副作用显著地比大剂量小,因此中剂量是治疗婴儿痉挛较好的选择。
出处 《陕西医学杂志》 CAS 2014年第5期548-549,共2页 Shaanxi Medical Journal
  • 相关文献

参考文献7

  • 1Hrachovy RA, Frost JD Jr. Infantile spasms[J]. Handb-Clin Neurol, 2013,111:611-618.
  • 2Jaseja H,Jaseja B,Badaya S, et al. Superior therapeuticefficacy of adrenocorticotrophic hormone (ACTH) in in-fantile spasms : emerging evidence [J]. Epilepsy Behav,2012 ,25(2):250-252.
  • 3Taylor JB, Young WO,Rutar T. Posterior subcapsularcataracts in children receiving adrenocorticotropic hor-mone (ACTH) for infantile spasms[J]. J Child Neurol,2010 ,25(8):1017-1019.
  • 4Gkampeta A,Pavlou E. Infantile spasms (West syn-drome) in children with inborn errors of metabolism: areview of the literature [J]. J Child Neurol, 2012 , 27(10):1295-1301.
  • 5Arya R, Shinnar S,Glauser TA. Corticosteroids for thetreatment of infantile spasms: a systematic review[J]. JChild Neurol, 2012 ,27(10) : 1284-1288.
  • 6Peltzer B,Alonso WD, Porter BE. Topiramate and adre-nocorticotropic hormone (ACTH) as initial treatment forinfantile spasms[J]. J Child Neurol, 2009 ,24(4):400-405.
  • 7Hancock EC,Osborne JP,Edwards SW. Treatment ofinfantile spasms[J]. Cochrane Database Syst Rev, 2013.6(6):1770.

同被引文献45

  • 1陈国利,张月华,秦炯,陈小荣,刘晓燕,包新华,姜玉武,吴晔,王爽,吴希如.促肾上腺皮质激素治疗婴儿痉挛的疗效及其影响因素[J].中国实用儿科杂志,2004,19(7):406-408. 被引量:5
  • 2Yulu Miao,Mingxia Zhang,Yulin Nie,Wan Zhao,Bin Huang,Zhengming Jiang,Shaoxiong Yu,Zhibin Huang,Hongjin Fu.Changes in T lymphocyte subsets after severe traumatic brain injury[J].Neural Regeneration Research,2007,2(2):126-128. 被引量:7
  • 3Covanis A. Clinical management of epileptic encephalopathies of childhood and infancy [ J ]. Expert Rev Neurother, 2014, 14 ( 6 ) : 687-701.
  • 4Yamanaka G, Kawashima H, Oana S, et al.Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome [ J ] .J N eurol Sci, 2010, 298(1-2) : 106-109.
  • 5Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy [ J ].Epilepsia, 1989,30 (4) : 389-399.
  • 6Shiihara T, Miyashita M, Yoshizumi M, et al.Perlpheral lymphocyte subset and serum cytokine profiles of patients with West syndrome FJ] .Brain Dev.2010.32(9) ,695-702.
  • 7Wanigasinghe J, Arambepola C, Sri Rm~ganathan S, et al.The efficacy of moderate-to-high dose oral prednisolone versus low-to-moderate dose intramuscular corticotrnpin for improvement of hypsarrhythmia in West syndrome : a randomized, single- blind, parallel clinical trial[ Jl .Pediatr Neurol,2014,51(1) :24-30.
  • 8Schwartz R A,Janniger C K,Michalowicz R,et al. Skin lesions in children with tuberous sclerosis complex:their prevalence, natural course,and diagnostic significance [ J]. International journal of dermatology, 1998,37 ( 12 ) :911-917.
  • 9林庆.关于小儿癫痫及癫痫综合征分类的建议[J].中华儿科杂志,1996,34(2):130-130.
  • 10Wang S, Fallah A. Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options [ J ]. Neuropsychiatric disease and treatment,2014,10:2021.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部